Finance

Lists
688076:SHA
Jiangsu Sinopep Allsin Bphrmctcl Co Ltd
CN¥26.72
-0.74%
(-0.20) 1D
Jul 23, 3:00:06 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688076...
Open
CN¥26.87
High
CN¥26.93
Low
CN¥26.33
Mkt. cap
9.26B
Avg. vol.
2.83M
Volume
1.75M
Dividend
1.31%
Quarterly dividend
CN¥0.09
Ex-dividend date
Jun 12, 2026
P/E ratio
27.24
52-wk high
CN¥50.86
52-wk low
CN¥25.70
EPS
CN¥0.98
No. of employees
2K
Open
CN¥26.87
High
CN¥26.93
Low
CN¥26.33
Mkt. cap
9.26B
Avg. vol.
2.83M
Volume
1.75M
Dividend
1.31%
Quarterly dividend
CN¥0.09
Ex-dividend date
Jun 12, 2026
P/E ratio
27.24
52-wk high
CN¥50.86
52-wk low
CN¥25.70
EPS
CN¥0.98
No. of employees
2K
News stories
From sources across the web
About Jiangsu Sinopep Allsin Bphrmctcl Co Ltd
CEO-
Employees2.36K
FoundedApr 3, 2009
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
482.68M
478.90M
415.62M
552.98M
Cost of goods sold
183.82M
129.28M
327.84M
210.32M
Cost of revenue
183.82M
129.28M
327.84M
210.32M
Research and development expenses
41.80M
66.28M
65.36M
53.12M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
98.25M
86.65M
116.57M
87.52M
Operating expense
147.79M
154.38M
173.35M
151.33M
Total operating expenses
331.61M
283.66M
501.19M
361.65M
Operating income
151.07M
195.24M
-85.57M
191.33M
Other non operating income
-3.67M
1.50M
633.51K
-8.53M
EBT including unusual items
162.42M
151.68M
-130.96M
150.48M
EBT excluding unusual items
140.65M
177.52M
-105.91M
168.85M
Income tax expense
7.93M
7.74M
-10.06M
23.59M
Effective tax rate
4.88%
5.10%
7.68%
15.67%
Other operating expenses
137.41K
-2.65M
-4.39M
-5.99M
Net income
157.43M
134.49M
-112.12M
129.46M
Net profit margin
32.62%
28.08%
-26.98%
23.41%
Earnings per share
0.30
0.34
-0.21
0.39
Interest and investment income
3.19M
3.20M
3.24M
2.24M
Interest expense
-14.04M
-18.31M
-20.20M
-16.19M
Net interest expenses
-10.85M
-15.12M
-16.96M
-13.95M
Depreciation and amortization charges
-
-
-
-
EBITDA
217.69M
245.71M
-10.31M
266.59M
Gain or loss from assets sale
-
-
6.43K
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more